
Decdan 0.5 Tablet
Wockhardt Ltd - Tablet - 10 Tablet
Prescription required
Dapagliflozin 10 mg + Metformin (as Metformin Hydrochloride) 1000 mg (Sustained Release)
Zinodap M5/1000 SR is used for type 2 diabetes mellitus: to improve glycaemic control in adults as an adjunct to diet and exercise, when dual therapy with metformin and an SGLT2 inhibitor is appropriate.
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Zinodap M5/1000 SR contains Dapagliflozin 10 mg + Metformin (as Metformin Hydrochloride) 1000 mg (Sustained Release). It belongs to the SGLT2 inhibitor + Biguanide class of medicines.
Dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion. Metformin decreases hepatic glucose production and improves insulin sensitivity; the SR form releases drug slowly to improve GI tolerability and provide prolonged effect.
Oral tablet (SR). Take exactly as prescribed, usually once daily with a meal (preferably with/after the main meal) to reduce stomach upset. Swallow whole; do not crush, chew or break. Maintain adequate hydration.
Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.
Take the missed dose of Zinodap M5/1000 SR as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.
Taking more Zinodap M5/1000 SR than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.
Most side effects of Zinodap M5/1000 SR are mild and settle as the body adjusts. Reported side effects include:
Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
| Pregnancy | Not recommended; consult doctor (generally avoid SGLT2 inhibitors in 2nd/3rd trimester; use only if clearly needed) |
|---|---|
| Alcohol | Avoid (increases risk of lactic acidosis and dehydration) |
| Habit forming | No |
Not for type 1 diabetes. Risk of lactic acidosis with metformin (higher risk in severe kidney impairment, dehydration, sepsis, hypoxia, alcohol abuse); stop and seek care for rapid breathing, severe weakness, abdominal pain. Dapagliflozin may cause genital mycotic infections, UTIs, volume depletion/low BP, and rarely ketoacidosis (can occur with normal sugars); stop and seek care for nausea, vomiting, abdominal pain, rapid breathing. Assess kidney function before and periodically; dose/use may be restricted in reduced eGFR. Withhold before major surgery and during acute illness or prolonged fasting; restart when stable and eating. Use caution in elderly, on diuretics, or with low BP. Consider vitamin B12 monitoring with long-term metformin. Inform doctor before iodinated contrast procedures; may need temporary discontinuation.
Insulin and sulfonylureas (increased hypoglycaemia risk), diuretics (increased dehydration/low BP risk), ACE inhibitors/ARBs (may enhance BP lowering), NSAIDs and nephrotoxic drugs (worsen renal function affecting metformin safety), alcohol (increases lactic acidosis risk), iodinated contrast media (risk of lactic acidosis—temporary stop), cationic drugs affecting renal tubular secretion e.g. cimetidine (may increase metformin levels)
Store below 25°C in a dry place, protected from moisture and light. Keep in original blister pack and out of reach of children.

Wockhardt Ltd - Tablet - 10 Tablet
Prescription required
Wockhardt Ltd - Injection - 1 ml - 1 S
Prescription required

Wockhardt Ltd - Tablet - 4 S
Prescription required

Wockhardt Ltd - 100 iu - 1 S
Prescription required
Wockhardt Ltd - 5 X3 ml
Prescription required

Wockhardt Ltd - 14 S
Prescription required

Wockhardt Ltd - 14 S
Prescription required

Wockhardt Ltd - Tablet - 15 S
Prescription required

IPCA Laboratories Ltd - 10 S
Prescription required
Alkem Lab - Tablet - 25 mg - 10 S
Prescription required

Shrrishti Healthcare Products(I) Pvt Ltd - Tablet - 10 S
Prescription required
Lividus Pharmaceuticals Pvt Ltd. - Tablet - 10 S
Prescription required

Alkem Lab - Tablet - 10
Prescription required

Icon Pharma - 10 S
Prescription required
Cresha Lifesciences - 10 S
Prescription required

Anceron Pharma - Tablet - 10 S
Prescription required
Dr Reddys Laboratories Ltd - 50 Gms
Prescription required

Dr Reddys Laboratories Ltd - Gel - 50 G
Prescription required

Wallace Pharmaceuticals Pvt Ltd - Powder - 4.2 G
Tablet - 10 Tablet
Prescription required

Scott Edil Pharmacia Ltd - Gel - 40 G
Prescription required

Abbott Healthcare Pvt Ltd - Syrup - 60 ml
Prescription required
Modi-Mundipharma Private Ltd - Tablet - 10 S
Prescription required

Procter & Gamble Hygiene And Health Care Ltd - 7 Piece
The information on Zinodap M5/1000 SR is compiled from the manufacturer's prescribing information and the sources below, and is reviewed by a registered medical practitioner. It does not replace advice from your own doctor.